Table 2.
Clinical outcomes and univariate comparisons between the sexually active (group A) and sexually inactive (group B) subjects during COVID-19 lockdown
| Variable | Overall (N = 6,821) | Group A (N = 2,608) | Group B (N = 4,213) | Statistics | Effect size (d or V) |
|---|---|---|---|---|---|
| n (%)/mean ± SD | n (%)/mean ± SD | n (%)/mean ± SD | |||
| Anxiety | |||||
| GAD-7 score | 6.78 ± 4.40 | 6.01 ± 4.23 | 7.26 ± 4.44 | t = −11.626∗ | d = 0.29 |
| Prevalence (%) | 1,624 (23.8%) | 478 (18.3%) | 1,146 (27.2%) | = 69.92∗ | V = 0.10 |
| Depression | |||||
| PHQ-9 score | 7.70 ± 5.07 | 6.73 ± 4.75 | 8.31 ± 5.17 | t = −12.898∗ | d = 0.32 |
| Prevalence (%) | 2,045 (30.0%) | 596 (22.9%) | 1,449 (34.4%) | = 102.20∗ | V = 0.12 |
| Dyadic adjustment | |||||
| Cohesion subscale | 15.86 ± 3.93∗ | 16.12 ± 3.84† | 15.58 ± 4.00‡ | t = 4.781∗ | d = 0.14 |
| Satisfaction subscale | 36.57 ± 7.42∗ | 37.00 ± 7.11† | 36.11 ± 7.72‡ | t = 4.113∗ | d = 0.12 |
∗P < .0001.
N = 4,757.
N = 2,466.
N = 2,291.